ENTX
Income statement / Annual
Last year (2023), Entera Bio Ltd.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Entera Bio Ltd.'s net income was -$8.89 M.
See Entera Bio Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00
|
$134,000.00
|
$571,000.00
|
$365,000.00
|
$236,000.00
|
$500,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$56,000.00 |
$101,000.00 |
$373,000.00 |
$209,000.00 |
$210,000.00 |
$0.00 |
$43,000.00 |
$35,000.00 |
$28,000.00 |
| Gross Profit |
-$56,000.00 |
$33,000.00 |
$198,000.00 |
$156,000.00 |
$26,000.00 |
$500,000.00 |
-$43,000.00 |
-$35,000.00 |
-$28,000.00 |
| Gross Profit Ratio |
0 |
0.25 |
0.35 |
0.43 |
0.11 |
1 |
0 |
0 |
0 |
| Research and Development
Expenses |
$4.51 M
|
$5.85 M
|
$6.77 M
|
$6.40 M
|
$7.20 M
|
$8.52 M
|
$2.77 M
|
$2.65 M
|
$2.12 M
|
| General & Administrative
Expenses |
$4.43 M
|
$7.25 M
|
$5.69 M
|
$4.89 M
|
$4.28 M
|
$2.84 M
|
$8.58 M
|
$2.72 M
|
$1.59 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$4.43 M
|
$7.25 M
|
$5.69 M
|
$4.89 M
|
$4.28 M
|
$2.84 M
|
$8.58 M
|
$2.72 M
|
$1.59 M
|
| Other Expenses |
$0.00 |
-$51,000.00 |
-$46,000.00 |
$1.24 M |
$743,000.00 |
$523,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$8.86 M |
$13.05 M |
$12.42 M |
$11.29 M |
$11.48 M |
$11.36 M |
$11.34 M |
$5.37 M |
$3.70 M |
| Cost And Expenses |
$8.86 M |
$13.15 M |
$12.79 M |
$11.50 M |
$11.69 M |
$11.36 M |
$11.34 M |
$5.37 M |
$3.70 M |
| Interest Income |
$31,000.00 |
$83,000.00 |
$0.00 |
$28,000.00 |
$84,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$29,000.00 |
$28,000.00 |
$84,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$56,000.00
|
$64,000.00
|
$53,000.00
|
$63,000.00
|
$238,000.00
|
$54,000.00
|
$43,000.00
|
$35,000.00
|
$28,000.00
|
| EBITDA |
-$8.80 M
|
-$12.87 M
|
-$12.16 M
|
-$11.11 M
|
-$11.35 M
|
-$10.81 M
|
-$11.05 M
|
-$5.33 M
|
-$3.67 M
|
| EBITDA Ratio |
0 |
-97.14 |
-21.3 |
-30.5 |
-47.53 |
-21.61 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
-97.14
|
-21.4
|
-30.5
|
-48.53
|
-21.72
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$31,000.00
|
$134,000.00
|
-$29,000.00
|
-$28,000.00
|
$659,000.00
|
$557,000.00
|
$146,000.00
|
$4.17 M
|
-$581,000.00
|
| Income Before Tax |
-$8.86 M |
-$12.93 M |
-$12.25 M |
-$9.96 M |
-$10.80 M |
-$10.30 M |
-$11.20 M |
-$1.20 M |
-$4.28 M |
| Income Before Tax Ratio
|
0
|
-96.52
|
-21.45
|
-27.3
|
-45.74
|
-20.61
|
0
|
0
|
0
|
| Income Tax Expense |
$29,000.00 |
$137,000.00 |
-$59,000.00 |
$20,000.00 |
$84,000.00 |
$557,000.00 |
-$146,000.00 |
$0.00 |
$0.00 |
| Net Income |
-$8.89 M |
-$13.07 M |
-$12.19 M |
-$9.98 M |
-$10.88 M |
-$10.30 M |
-$11.20 M |
-$1.20 M |
-$4.28 M |
| Net Income Ratio |
0 |
-97.54 |
-21.34 |
-27.35 |
-46.1 |
-20.61 |
0 |
0 |
0 |
| EPS |
-0.31 |
-0.45 |
-0.47 |
-0.54 |
-0.9 |
-1.3 |
-1.31 |
-0.14 |
-0.36 |
| EPS Diluted |
-0.31 |
-0.45 |
-0.47 |
-0.54 |
-0.9 |
-1.29 |
-0.94 |
-0.1 |
-0.36 |
| Weighted Average Shares
Out |
$29.01 M
|
$28.81 M
|
$26.13 M
|
$18.42 M
|
$12.15 M
|
$7.96 M
|
$8.57 M
|
$8.57 M
|
$11.90 M
|
| Weighted Average Shares
Out Diluted |
$29.01 M
|
$28.81 M
|
$26.13 M
|
$18.42 M
|
$12.15 M
|
$7.98 M
|
$11.90 M
|
$11.90 M
|
$11.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
